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Abstract
Exposure of adult humans to manganese (Mn) has long been known to cause neurotoxicity. Recent
evidence also suggests that exposure of children to Mn is associated with developmental
neurotoxicity. Astrocytes are critical for the proper functioning of the nervous system, and they play
active roles in neurogenesis, synaptogenesis and synaptic neurotransmission. In this report, to help
elucidate the molecular events underlying Mn neurotoxicity, we systematically identified the
molecular targets of Mn in primary human astrocytes at a genome-wide level, by using microarray
gene expression profiling and computational data analysis algorithms. We found that Mn altered the
expression of diverse genes ranging from those encoding cytokines and transporters to signal
transducers and transcriptional regulators. Particularly, 28 genes encoding proinflammatory
chemokines, cytokines and related functions were up-regulated whereas 15 genes encoding functions
involved in DNA replication and repair and cell cycle checkpoint control were down-regulated.
Consistent with the increased expression of proinflammatory factors, analysis of common regulators
revealed that 16 targets known to be positively affected by the interferon-! signaling pathway were
up-regulated by Mn2+. In addition, 68 genes were found to be similarly up- or down-regulated by
both Mn2+ and hypoxia. These results from genomic analysis are further supported by data from real-
time RT-PCR, Western blotting, flow cytometric and toxicological analyses. Together, these analyses
show that Mn2+ selectively affects cell cycle progression, the expression of hypoxia-responsive
genes, and the expression of proinflammatory factors in primary human astrocytes. These results
provide important insights into the molecular mechanisms underlying Mn neurotoxicity.
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Manganese (Mn) is an essential metal required for many enzymatic reactions such as those
catalyzed by arginase, glutamine synthetase and manganese-dependent superoxide dismutase.
However, elevated Mn exposures can lead to its accumulation in the brain and causes serious
neurotoxicity (Crossgrove and Zheng, 2004;Dobson et al., 2004;Erikson et al., 2004a;Hazell,
2002;Newland, 1999;Pal et al., 1999). In humans, Mn deficiency is rare whereas Mn
neurotoxicity or manganism can occur due to occupational and environmental exposures
(Crossgrove and Zheng, 2004;Pal et al., 1999). It is estimated that over 3700 tons of Mn are
released into the atmosphere every year (2001), particularly from the gasoline additive,
methylcyclopentadienyl manganese tricarbonyl (MMT). Signs of manganism resemble those
of idiopathic Parkinson's disease, including dystonia, bradykinesia, rigidity, and tremor
(Barbeau, 1984;Newland, 1999;Pal et al., 1999). In exposed humans and monkeys, Mn
accumulates at the highest levels in the striatum, globus pallidus, and substantia nigra (Erikson
et al., 2004a). In monkeys dosed for three months with MnO2, Mn concentrations reached 264
µM in the striatum and 334 µM in the globus pallidus (Suzuki et al., 1975). Mn exposure may
also cause developmental neurotoxicity in children. A recent cross-sectional study of 201 ten
year-old children living in Araihazar, Bangladesh showed that water Mn was significantly and
adversely associated with Performance and Full Scale raw intelligence score (Wasserman et
al., 2005).
Previous studies have suggested that Mn2+ can induce oxidative stress and affect iron
metabolism and cellular energy metabolism (Dobson et al., 2004;Erikson et al., 2004a;Hazell,
2002;Li et al., 2005;Lu et al., 2005). Nonetheless, the understanding of the specific mechanisms
underlying Mn neurotoxicity in humans remains far from clear. In mammals, Mn is absorbed
and transported to the brain by the mechanisms responsible for the uptake of divalent metal
ions, including the DMT-1-mediated and transferrin-mediated pathways (Erikson and Aschner,
2006;Erikson et al., 2004b). In the brain, astrocytes are a “sink” for Mn, with concentrations
10-50-fold higher than in neurons (Erikson and Aschner, 2006;Erikson et al., 2004b). Mn
transport to astrocytes is significantly affected by Fe status. Also, evidence suggests that Mn
transport involves multiple pathways that may be competitive or synergistic with iron transport
(Crossgrove and Yokel, 2005;Erikson and Aschner, 2006;Erikson et al., 2004b).
In this report, we focus on the potential effects of Mn on human astrocytes. Astrocytes play
active roles in many neuronal functions: maintaining ion and pH homeostasis, promoting the
synthesis and removal of neurotransmitters, providing glucose supply and antioxidant defense,
and regulating synaptic activity, synaptogenesis and neurogenesis (Auld and Robitaille,
2003;Magisretti and Ransom, 2002;Newman, 2003). Astrocytes are sensors of the brain
environment, to which they immediately react on the genomic (gene expression) and non-
genomic levels (Nedergaard and Dirnagl, 2005). Inflammatory activation of astrocytes or
astrocyte dysfunctions are believed to be associated with several chronic neurological diseases,
including prion, Alzheimer's and Parkinson's Diseases, and HIV-1 associated dementia (HAD)
(Burwinkel et al., 2004;Choi et al., 2005;Meda et al., 2001;Wang et al., 2004). If Mn
neurotoxicity is linked with inflammation, it is plausible that the initiating events may occur
in astrocytes. One purpose of this study is to test the hypothesis that Mn may induce the
expression of inflammatory mediators in astrocytes.
A new powerful way to begin identifying molecular targets of pathogenic insults to cells is to
use microarray technology to obtain a general gene expression profile of affected versus control
cells. Candidate affected genes and their functions can then be subjected to in-depth analysis
to determine the mechanisms of their responses to a given stimulus. Here we applied this
approach to identify candidate genes and gene families in human primary astrocytes that are
affected by exposure of the cells to Mn2+. Furthermore, we applied biochemical and
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toxicological methods to confirm the prominent effects of Mn2+ in primary human astrocytes.
Our studies suggest that Mn2+ selectively affects cell cycle progression and the expression of
hypoxia-responsive genes and proinflammatory factors. These results provide new insights
into the mechanisms underlying Mn neurotoxicity.
Materials and Methods
Primary human astrocytes and treatment
Astrocytes were isolated from second trimester (14–19 weeks of gestational age) human fetal
brains obtained from elective abortions in full compliance with NIH guidelines, as previously
described by Dr. Volsky and colleagues (Canki et al., 2001;Wang et al., 2004). Homogenous
preparations of astrocytes were obtained using high-density culture conditions in the absence
of growth factors in F12 Dulbecco's modified Eagles Medium (DMEM-F12) (GIBCO-
Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (FBS), penicillin, streptomycin,
and gentamycin. Cells were maintained in this medium at 2–5 × 104 cells/cm2 and subcultured
weekly up to six times. Cultures were regularly monitored by immunofluorescence staining
for expression of the astrocytic marker glial fibrillary acidic protein (GFAP) and HAM-56 to
identify cells of the monocyte lineage. Only cultures that contained "99% GFAP-positive
astrocytes and no detectable HAM-56-positive cells were used in the experiments. Primary
human astrocytes were treated with or without 200 µM MnCl2.
Cell growth and LDH assays
To measure the effect of MnCl2 on the growth rate of primary human astrocytes, 1.2×104 cells
were plated on each well of 24-well plates. Cells were treated with the desired concentrations
of MnCl2 for 7 days. Then, adherent, live cells were collected by trypsin treatment, and the
number of cells was accounted by using a hemacytometer. At least three independent sets of
data were collected in each experiment. To assess the effect of MnCl2 on cell viability of
astrocytes, we measured the release of lactate dehydrogenase (LDH) into the medium. In this
case, 7.5×104 cells were plated on each well of 24-well plates and treated with the desired
concentrations of MnCl2 for 7 days. The medium was collected, and lactate dehydrogenase
(LDH) activities were measured and calculated by using a kit purchased from Sigma (Saint
Louis). The total cellular LDH activity was measured by detecting the activity in Triton X-100
lysed cells (Ehrich and Sharova, 2000).
RNA extraction and Affymetrix GeneChip expression analysis
Primary human astrocytes (passage 4) were treated with or without 200 µM MnCl2 for 7 days.
Total RNA was extracted by using TRIzol reagent (GIBCOBRL Life Technologies). The
quality of RNA was high as assessed by measuring absorbance at 260 and 280 nm, by gel
electrophoresis, and by the quality of microarray data (see below). We isolated RNA from three
independent batches of human astrocytes, which were from different subjects. No identifiable
information from these subjects was available, in keeping with the guidelines on human
subjects. Three independent batches of astrocytes from three different subjects, not the same
subject, were used to ensure that our data and conclusions would not totally rely on one
unidentified subject, who may have experienced influential environmental or genetic
conditions. The synthesis of cDNAs and biotin-labeled cRNAs were carried out exactly as
described in the Affymetrix GeneChip Expression Analysis Technical Manual (2000). The
human genome U133 plus 2.0 arrays were purchased from Affymetrix, Inc. Probe hybridization
and data collection were carried out by the Columbia University Affymetrix GeneChip
processing center. Initial data analysis was performed by using the Affymetrix Microarray
suite.
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Computational analysis of microarray data
We analyzed microarray expression data by applying a series of quality control, statistical,
filtering, gene ontology, and pathway analysis algorithms. First, by using GCOS1.2 with the
advanced PLIER (probe logarithmic intensity error) algorithm, we calculated and examined
the parameters reflecting the image quality of the arrays. Arrays with a high background level
in any region were discarded and replaced. The average noise or background level was limited
to less than 5%. The average intensity for those genes judged to be present was at least 10-fold
higher than those judged to be absent. Also, arrays that deviated considerably in the percentage
of present and absent genes from the majority of the arrays were replaced. Arrays with a #-
actin 3$/5$ ratio greater than 2 were replaced. Next, microarray data were uploaded to
GeneSpring 7.0 (Silicon Genetics) for further quality and statistical analysis. The data were
normalized again by using the stringent per chip and per gene normalization algorithms; genes
with low control signal (less than average) or not present in 1/3 of the samples were dropped
out, before statistical analysis. The data were then analyzed by nonparametric two-way
ANOVA (one parameter is cell, another parameter is treatment). The Benjamini & Hochberg
false discovery rate multiple testing correction was applied with a false discovery rate of less
than 5%. Two-way ANOVA was chosen for statistical analysis because the variations of
astrocytes from different subject can be significant, and in certain cases, may exert stronger
effects than the treatment of cells. Two-way ANOVA would take account of this and identify
statistically significant genes whose transcript level was consistently altered by Mn. Second,
to identify genes whose transcript level was significantly altered by Mn, we applied four
consecutive filtering processes: The first three were applied to identify genes whose transcript
level was altered by at least 1.5-fold (Mn-treated vs control) in every batch of human astrocytes.
The last one was applied to identify genes whose overall transcript level calculated from three
independent batches of astrocytes was altered by at least 2-fold. The folds of changes listed in
the Tables are the overall changes calculated from data from the three batches of astrocytes by
GeneSpring, which combines data from all three controls and three Mn2+-treated samples.
The identified Mn2+-altered genes were further analyzed and categorized by using various
biological annotation programs including the DAVID/EASE program provided by NIAID
(http://apps1.niaid.nih.gov/david/upload.asp) and the Gene Ontology (GO) algorithm in
GeneSpring. Data from OMIM and the literature were also used to categorize the genes. Our
analyses led to the identification of six notable functional groups of genes whose expression
is altered by Mn2+ (see Results). Finally, we used another computational program called
PathwayAssist (Stratagene Software) to analyze Mn2+-altered genes. This program uses
information available in the current literature to identify common pathways, targets or
regulators that are associated with the altered genes.
Quantitative real-time reverse-transcription-polymerase chain reaction (real-time RT-PCR)
Oligonucleotide primers for measuring transcript levels of genes were designed based on the
sequences used to design microarray probes by using the primer 3 program (http://
frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). #-actin was used as a control for the
relative quantification of transcripts, because our microarray data showed that the #-actin
transcript level was unaffected by Mn2+. RT-PCR reactions were performed by using a Roche
LightCycler and the SYBR green kit according to specified protocols. Calculations were done
by using the Roche LightCycler software (Bustin, 2002;Giulietti et al., 2001;Livak and
Schmittgen, 2001). Primer sequences used for real-time PCR are listed in supplemental Table
S1.
Flow cytometric analysis
Primary human astrocytes, seeded at 2×105 cells/cm2, were treated with no reagent (control)
or 200 µM MnCl2 (Mn-treated) for 7 days. Then cells were collected by trypsinization and
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prepared for FACS analysis, as described (Darzynkiewicz et al., 1999). Briefly, cells were
fixed in 70% ethanol and then stained with propidium iodide. 106 to 107 cells were used for
each FACS analysis at the Columbia University Medical Center FACS analysis facility. Flow
cytometric analysis was performed by using a Becton-Dickinson FACSCalibur instrument.
Data were acquired by using the CellQuest PRO (Becton-Dickinson) software, and were
analyzed by combining CellQuest PRO and FloJo (TreeStar) software.
Western blotting analysis
Astrocytes were washed twice in PBS, and whole-cell extracts were prepared by adding 10
packed cell volumes of 1x sample buffer (2% SDS, 100 mM dithiothreitol, 60 mM Tris pH
6.8, and 10% glycerol) and boiled for 5 minutes. Protein concentrations were determined by
using the bicinchoninic acid (BCA) protein assay kit (Pierce). Approximately 20 µg protein
was analyzed on 9% SDS-PAGE and transferred onto the Immuno-Blot PVDF Membrane
(Bio-Rad). The membranes were probed with polyclonal antibodies, followed by detection
with a chemiluminescence Western blotting kit (Boehringer Mannheim). Polyclonal antibodies
against SOD2, COX2 and #-actin were purchased from Santa Cruz Biotechnology, Inc., Abcam
Inc. and Cell Signaling Technology, respectively. The primary antibodies were used at 1:1000
dilution, while the secondary antibody was used at 1:2500 dilution.
Results
Mn2+ alters the transcript levels of a subset of genes with distinctive functional
characteristics
Previous studies of Mn-exposed monkeys and rats showed that Mn concentration in the
striatum and globus pallidus can reach concentrations higher than 200 µM (Erikson et al.,
2004a;Suzuki et al., 1975). In addition, Mn concentration in astrocytes can be much higher
than in neurons. Thus, to maximize the likelihood of identifying Mn targets that may be relevant
to human exposures, we chose to examine the effect of 200 µM Mn on primary human
astrocytes. We performed microarray gene expression analysis by using RNA samples from
three independent batches of primary human astrocytes, treated with or without MnCl2 for 7
days. We used a series of quality control, normalization, statistical and filtering analysis
algorithms to identify the differentially expressed genes in Mn2+-treated vs. untreated
astrocytes, see Materials and Methods. We identified genes whose overall expression level in
three independent batches of astrocytes was altered by > 2-fold and whose expression level in
each batch of astrocytes was altered by >1.5-fold. We used these stringent statistical criteria
to minimize the identification of false positive targets.
We identified 734 genes whose expression was selectively altered by Mn2+ (Table 1). 414 were
up-regulated while 320 were down-regulated. Among them, about 316 are annotated to date
(Table 1). The transcript levels of these altered genes in three different batches of astrocytes
were displayed in Figure 1A (up-regulated) and 1B (down-regulated). By using the NIH
program DAVID, PubMed, and the gene ontology algorithm GeneSpring, we identified several
functionally distinctive classes of genes altered by Mn2+. These identified categories included
genes encoding cytokines and inflammatory functions, regulators of cell cycle, DNA
replication and repair, transporters, functions involved in development, transcriptional
regulators and signal transducers (Table 1).
To confirm the results form microarray gene expression profiling, we used real-time RT-PCR
analysis. We selectively examined the transcript levels of a series of Mn2+-altered genes,
particularly those encoding inflammatory mediators, such as CD48, CR1, CXCL2, CD8B1,
CXC3, and IL12A. Figure 2A shows that consistent with microarray data, Mn2+ significantly
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induced the expression of CD48, SOD2, CR1, CXCL2, CD8B1, IL12A, CNOT6L, GAL,
HEPH (hephaestin), MYT1L, POU1F1, SULT1C1, and CXCL3.
In addition, we performed dose-response analysis of SOD2 and CXCL2 transcript levels
(Figure 2B and C). We found that 200 µM Mn2+ dramatically increased their transcript levels,
whereas 10 µM and 50 µM Mn2+ did not (Figure 2B and 2C). This dose-response pattern is
further confirmed by Western blotting analysis. As shown in Figure 3, 200 µM Mn2+
significantly increased SOD2 (Figure 3A) and COX2 (Figure 3B) protein levels (Figure 3),
although 10 or 50 µM did not, after 7 days of treatment. Still, this effect of Mn2+ is likely
relevant to human exposures, because Mn2+ concentration can reach higher than 200 µM in
the brain and because Mn2+ can be elevated further in astrocytes (Erikson and Aschner,
2006;Fitsanakis et al., 2006;Suzuki et al., 1975). These results from real-time RT-PCR and
Western blotting analyses support the validity of our microarray gene expression analysis.
A group of genes encoding functions involved in cell cycle control and DNA replication and
repair was selectively down-regulated
We found that 15 genes encoding functions involved in DNA replication and repair and cell
cycle checkpoint control were down-regulated (Tables 1 and 2). Among these, of particular
interest are ATM kinase (ataxia telangiectasia mutated), the checkpoint kinase BUB1, the
Fanconi anemia FANCF protein, two subunits of DNA primase PRIM1 and PRIM2A, and the
replication factor RFC5 (Abraham and Tibbetts, 2005;Margolis, 2004). Remarkably, by using
flow cytometric analysis, we found that Mn2+ caused the accumulation of astrocytes in the S
phase of the cell cycle (Table 3). This effect on cell cycle is entirely consistent with the effect
of Mn2+ on the expression of genes involved in DNA replication and repair, as described above.
Very likely, cells accumulated in the S phase cannot progress further and stop growing. Indeed,
we found that the growth rate of Mn2+-treated astrocytes was significantly reduced (Figure
4A). However, no apoptotic cells were detected by TUNEL assays, even after prolonged
incubation with 200 µM Mn2+ for 2 weeks (not shown). The lack of cell death is also supported
by the measurement of LDH release to the medium. As shown in Figure 4B, LDH release to
the medium in cells treated with 200 µM Mn2+ was barely increased by 2% (from 6.6% in
untreated cells to 8.8%). This increase is only of marginal statistic significance, with a p-value
of 0.06 (Figure 4B).
A group of genes encoding cytokines and immune functions was selectively up-regulated
in Mn2+-treated human astrocytes
Mn2+ appears to induce the transcript levels of a group of genes that encode cytokines,
chemokines and other immune functions in primary human astrocytes (Tables 1 and 4).
Specifically, Mn2+ up-regulated a series of proinflammatory cytokines and chemokines,
including CCL7 (MCP3), CXCL14, CXCL2 (MIP2A), CXCL3 (MIP2B), CXCL6 (GCP2),
defensin DEFB103, epiregulin EREG, and interleukins IL12A and IL7 (Tables 1 and 4). Other
up-regulated pro-inflammatory or immune functions include CD40 and CD8 antigen, the DR
subunit of the class II major histocompatibility complex HLA-DRB4, cyclooxygenase COX2
(PTGS2), and pentaxin-related gene PTX3 (Parslow et al., 2001). Notably, the transcript levels
of several angiogenic growth factors, including adrenomedullin (ADM), angiopoietin-like 4
(ANGPTL4), placental growth factor (PGF), and vascular endothelial growth factor (VEGF),
were up-regulated (Tables 4 and 5). These factors are also induced by hypoxia in various cells
(Iimuro et al., 2004;Manalo et al., 2005;Tait and Jones, 2004). In another study, we identified
hypoxia-responsive genes in human astrocytes (Mense et al., 2006). Comparison of hypoxia-
responsive genes with Mn2+-responsive genes identified 68 genes that were affected by
hypoxia and Mn2+ in the same manner (Table 5). Fifty genes were up-regulated, and 18 genes
were down-regulated by both Mn2+ and hypoxia in primary human astrocytes (Table 5).
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Mn2+ caused changes in the transcript levels of a number of transporters
Our gene ontology analyses identified 18 genes encoding functions involved in the transport
of proteins, small molecules and ions that were up-regulated while an equal number of genes
were down-regulated (Table 1 and Supplemental Table S2). These transporters include ABC
transporters (up-regulated, ABCA9; and down-regulated, ABCA5); cholesterol transporters
APOL1 and APOL2; transporters of small molecules and ions, including SLC11A2 (DMT1),
SLC16A3, SLC2A13, SLC22A15, SLC4A10; functions involved in Ca2+ entry, including the
channel proteins TRPM1 and TRPM4, and the inhibitor of Ca2+ channel phospholamban PLN;
functions involved in membrane and vesicle trafficking RAB21, RAB23, SEC15L1 and
VPS13A; and the nuclear import receptor importin IPO11 (Harteneck, 2005;Plafker and
Macara, 2000). Interestingly, a recent microarray analysis of gene expression in the prefrontal
cortex of schizophrenia and control brains revealed the significant up-regulation of the APOL1
and APOL2 genes (Mimmack et al., 2002).
Mn2+ altered the transcript levels of a number of genes encoding developmentally relevant
functions
Our analyses identified 38 (up-regulated, 25; down-regulated, 13) additional Mn2+-altered
genes (besides those relevant ones shown in Tables 2, 4 and S2) encoding developmentally-
relevant functions (Tables 1 and supplemental Table S3). Among the up-regulated 25 genes
(supplemental Table S3), CELSR1, neuregulin NRG2, neuropilin NRP1, calcyclin S100A6
and transcriptional regulators POU1F1, NOTCH4, FOXP2 and TFAP2B (Mani et al., 2005)
are known to play important roles in mammalian neural development or are expressed in neural
cells. Notably, neuregulin NRG2 (Michailov et al., 2004) (Table S3), a member of the ERBB
family of tyrosine kinase transmembrane receptors including the EGF receptor, and epiregulin
(Park et al., 2004), a member of the epidermal growth factor family (Table 4), were both up-
regulated. Likewise, neuropilin NRP1 (Castellani, 2002), a receptor for VEGF (Table S3), and
VEGF (Table 4), were both up-regulated. Evidently, both the EGF and VEGF signaling
pathways may be affected by Mn2+ in astrocytes.
The transcript levels of a number of signal transducers and transcriptional regulators were
altered by Mn2+
The effects of Mn2+ on gene expression (Table 1) are presumably mediated by their effects
(direct or indirect) on the levels or activities of transcriptional regulators and/or their upstream
effectors, i.e., signal transducers. Thus, it is expected that the expression of certain
transcriptional regulators and signal transducers would be altered by Mn2+. Indeed, our
analyses identified a series of signal transducers and transcriptional regulators whose transcript
level was altered by Mn2+. In total, we identified about 41 altered signal transducers and 30
altered transcriptional regulators (Table 1). Tables S4 and S5 list those additional 21 altered
signal transducers and 19 altered transcriptional regulators, besides those already shown in
Tables 2, 4, S2, and S3, such as IGB5, FOXP2 and POU1F1. The alteration of the transcript
levels of some of these signal transducers and transcriptional regulators would likely contribute
to the alteration of downstream genes shown in Tables 2, 4, S2, and S3, although too little is
known to correlate these regulators with their downstream effects in most cases. Interestingly,
the hypoxia-inducible factor HIF1A was up-regulated whereas its inhibitor HIF1AN (Mahon
et al., 2001) was down-regulated. This opposing effect of Mn2+ on HIF1A and HIF1AN
expression is in complete agreement with their perspective functions and with the result that
68 genes, such as ADM and VEGF (Table 5), that were induced/suppressed by Mn2+ were also
induced/suppressed by hypoxia (Mense et al., 2006).
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The IFN-! and EGF signaling pathways might be perturbed by Mn2+ in primary human
astrocytes
To identify common signaling pathways that may mediate the effects of Mn2+ on gene
expression, we used a computational program called PathwayAssist (Stratagene Software). We
found that Mn2+ altered the transcript levels of genes that are targets of the IFN-! signaling
pathway (Schroder et al., 2004) and the EGF signaling pathway (Schlessinger, 2004). Twenty-
six altered genes are known to be the targets of the IFN-! signaling pathway while 11 are known
to be the targets of the EGF signaling pathway (Table 6). Particularly, among those targets of
the IFN-! signaling pathway, 20 of them were shown to be positively affected by the IFN-!
signaling pathway in certain human cells, and 16 out of 20 were also up-regulated by Mn2+
(see italicized genes in Table 6).
Discussion
In this report, we applied microarray gene expression profiling and computational algorithms
to identify molecular targets of the common environmental toxicant Mn2+ in primary human
astrocytes. Further, we used real-time RT-PCR, Western blotting, flow cytometric, and
toxicological analyses to confirm the key results from microarray expression analysis. Our
analyses provide several new insights into the molecular neurotoxic actions of Mn. Such
insights may provide a molecular basis for further studies to elucidate the molecular events
underlying Mn neurotoxicity in humans. First, data from microarray expression profiling
(Table 2), flow cytometry (Table 3), and measurement of cell growth and LDH release (Figure
4) show that Mn2+ selectively affected astrocyte cell proliferation, while it did not significantly
affect cell death.
Second, 68 induced/suppressed genes by Mn2+, such as angiogenic factors (e.g., ADM,
ANGPTL4 and VEGF) and SOD2 (Table 5), were also induced/suppressed by hypoxia.
Consistent with this, we found that 11 target genes of the EGF signaling pathway were also
targeted by Mn2+ (Table 6). In a previous analysis (Mense et al., 2006), we found that hypoxia
induced nearly 40 genes that are targets of the EGF signaling pathway. These results raise the
possibility that Mn treatment and hypoxia act on a significant number of common target genes
and that Mn treatment resembles certain aspects of brain hypoxia or ischemia.
Third, a series of genes encoding proinflammatory functions was up-regulated by Mn2+ (Table
4). Particularly, the transcript levels of several genes encoding proinflammatory chemokines,
CCL7 (MCP3), CXCL14, CXCL2 (MIP2A), CXCL3 (MIP2B) and CXCL6 (GCP2), and
interleukins IL12A and IL7, were all enhanced in Mn2+-treated astrocytes. Proinflammatory
chemokines and cytokines are thought to play a critical role in the induction and perpetuation
of inflammation in the brain (Burwinkel et al., 2004;Choi et al., 2005;Meda et al., 2001).
Furthermore, 16 known targets of the IFN-! signaling pathway that are activated by the pathway
were also activated (Table 6), suggesting the IFN-! signaling pathway was activated in
Mn2+-treated astrocytes although the transcript level of IFN-! per se was not detected to be
increased. IFN-! plays a major immunomodulatory role in astrocytes, and the activation of its
signaling pathway leads to the expression of various inflammation-associated molecules (Choi
et al., 2005;Lin et al., 2004), as those shown in Tables 4 and 6. Glial activation and the
production of proinflammatory chemokines and cytokines have been shown to be associated
with many central nervous system (CNS) diseases, such as bacterial or viral infection, multiple
sclerosis, prion infection, Parkinson's disease, Alzheimer's disease and ischemia (Burwinkel
et al., 2004;Choi et al., 2005;Meda et al., 2001).This association is in complete agreement with
our findings that proinflammatory chemokines and cytokines are up-regulated and that the
IFN-! signaling pathway may be activated by Mn2+ in astrocytes.
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Interestingly, several genes shown in Tables S4 and S5 are known to be expressed in the brain
and/or to play important roles in the proper CNS functioning. These include the GABA A
receptor GABRG2, galanin (GAL), the G protein-coupled receptor GPR24, protocadherins
PCDH7 and PCDHA6, RGS2, catenins CTNNA1 and CTNNB1, poliovirus receptor PVR, the
neurokinin 1 receptor TACR1, presenilin binding protein CSEN, and myelin transcription
factor 1-like MYT1L. Particularly, galanin is a 29 amino acid neuropeptide that plays many
important roles in CNS (Robinson, 2004). It can modulate gastrointestinal motility, pituitary
hormone release, neurotrophic action, nociception, anxiety, feeding and cognition (Robinson,
2004;Wrenn et al., 2004). GPR24 (MCHR1) may be involved in the control of obesity,
depression and/or anxiety (Georgescu et al., 2005). CSEN appears to play important roles in
pain processing (Cheng et al., 2002) while MYT1L is expressed in neural cells of the
developing mammalian CNS (Kim et al., 1997).
In summary, our studies using a combination of genomic, biochemical and toxicological
approaches uncovered several note-worthy characteristics of the effects of Mn2+ on primary
human astrocytes. The most striking characteristics include its effects on cell cycle progression,
the expression of hypoxia-responsive genes and the expression of proinflammatory factors.
The effects of Mn2+ on the expression of hypoxia-responsive genes and proinflammatory
factors are consistent with the previous finding that the production of proinflammatory
cytokines is increased in mouse astrocytes following ischemia (Lau and Yu, 2001). Our
findings provide a molecular basis for further investigation of the mechanisms underlying Mn
neurotoxicity and perhaps even other neurodegenerative diseases. With a better understanding
of the functions of signal transducers and transcriptional regulators and mechanisms of gene
regulation, our data may provide further insights into the molecular events underlying Mn
neurotoxicity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Graphic illustration of the normalized expression levels of Mn2+-altered genes in primary
human astrocytes. Primary human astrocytes were treated with or without 200 µM Mn2+ for 7
days. RNA samples were extracted from these cells, and cRNA probes were generated and
were hybridized to the Human Genome U133 Plus 2.0 arrays and scanned. Data were analyzed
by using various algorithms in GeneSpring, including nonparametric two-way ANOVA, and
with the Benjamini & Hochberg false discovery rate multiple testing correction (p-value less
than 0.05). The differentially expressed genes in Mn2+-treated vs. untreated cells were
subjected to four consecutive filtering processes to identify genes whose overall expression
level in three independent batches of astrocytes was altered at least twofold and whose
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expression level in each batch of astrocytes was altered at least 1.5-fold. The expression levels
of up-regulated genes (Top) and down-regulated genes (Bottom) by Mn2+ in three batches of
independent astrocytes were plotted.
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(A) Real-time RT-PCR analysis of the induction of the transcript levels of genes induced by
Mn2+ in primary human astrocytes. Total RNA from three to six independent batches of human
astrocytes was isolated, and real-time RT-PCR analysis was performed as described in
Materials and Methods. #-actin was used as an internal standard. The folds of induction of the
indicated transcript levels were calculated by using Roche software, as described in Materials
and Methods. Abbreviations: CD48, CD48 antigen (B-cell membrane protein); SOD2,
superoxide dismutase 2; CR1, complement component receptor 1; CXCL2, chemokine (C-X-
C motif) ligand 2; CD8B1, CD8 antigen, beta polypeptide; IL12A, interleukin 12A; CNOT6L,
CCR4-NOT transcription complex, subunit 6-like; GAL, galanin; HEPH, hephaestin; MYT1L,
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myelin transcription factor 1-like; POU1F1, POU domain, class 1, transcription factor 1;
SULT1C1, sulfotransferase family, cytosolic, 1C, member; and CXCL3, chemokine (C-X-C
motif) ligand 3. (B) Real-time RT-PCR analysis of the CXCL2 transcript level at different
MnCl2 concentrations. Total RNA was isolated from human astrocytes treated with 0, 10, 50,
or 200 µM MnCl2 for 7 days, and real-time RT-PCR analysis of CXCL2 transcript was
performed as in A. (C) Real-time RT-PCR analysis of the SOD2 transcript level at different
MnCl2 concentrations. Total RNA was isolated from human astrocytes treated with 0, 10, 50,
or 200 µM MnCl2 for 7 days, and real-time RT-PCR analysis was performed as in A.
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The effect of MnCl2 on the protein levels of SOD2 (A) and COX2 (B). Human astrocytes were
treated with 0, 10, 50, or 200 µM MnCl2 for 7 days. Then protein extracts were prepared and
subjected to Western blotting analysis. The PVDF membranes were probed with antibodies
against SOD2, COX2 and #-actin, respectively. Equal amounts of cellular proteins were loaded
in every lane.
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(A) The effect of MnCl2 on the growth of primary human astrocytes. Human astrocytes were
treated with 0 or 200 µM MnCl2 for 7 days. Then, cells were counted as described in Materials
and Methods. The data plotted here were calculated from six independent experiments. The
error bars are plotted, but are too small to be discernable. (B) The effect of MnCl2 on LDH
release by primary human astrocytes. Human astrocytes were treated with 0, 10, 50, or 200
µM MnCl2 for 7 days. Then, LDH released to medium was measured and calculated as
percentage of total cellular LDH activity, as described in Materials and Methods. The data
plotted here were calculated from six independent experiments. Two-tailed t-tests were
performed to compare MnCl2-treated cells with untreated cells. P values were calculated by
using the SAS software.
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Table 3
The effect of Mn on cell cycle progression*
Control Mn-treated p-value
G1 55.8±0.9 36.7±1.3 0.0003
S 36.3±1.1 54.9±1.3 0.0003
G2 3.8±0.7 4.5±0.2 0.57
*
Primary human astrocytes treated with no reagent (control) or 200 µM MnCl2 (Mn-treated) for 7 days were subjected to flow cytometric analysis as
described in Materials and Methods. The shown data are averages from three experiments, and the two-tailed t-test p-value was calculated by using the
SAS software.
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